| Product Code: ETC9972878 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Paresthesia Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Paresthesia Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Paresthesia Market - Industry Life Cycle |
3.4 United States (US) Paresthesia Market - Porter's Five Forces |
3.5 United States (US) Paresthesia Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Paresthesia Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Paresthesia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 United States (US) Paresthesia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United States (US) Paresthesia Market Revenues & Volume Share, By End- Users, 2021 & 2031F |
4 United States (US) Paresthesia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as diabetes leading to neuropathic pain |
4.2.2 Rising geriatric population in the United States |
4.2.3 Technological advancements in neuromodulation devices for paresthesia treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for paresthesia devices approval |
4.3.2 High cost associated with paresthesia treatment |
4.3.3 Limited awareness among patients and healthcare providers about paresthesia treatment options |
5 United States (US) Paresthesia Market Trends |
6 United States (US) Paresthesia Market, By Types |
6.1 United States (US) Paresthesia Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Paresthesia Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Paresthesia Market Revenues & Volume, By Acute Paresthesia, 2021- 2031F |
6.1.4 United States (US) Paresthesia Market Revenues & Volume, By Chronic Paresthesia, 2021- 2031F |
6.2 United States (US) Paresthesia Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Paresthesia Market Revenues & Volume, By Immunosuppressant, 2021- 2031F |
6.2.3 United States (US) Paresthesia Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.2.4 United States (US) Paresthesia Market Revenues & Volume, By Tropical Creams, 2021- 2031F |
6.2.5 United States (US) Paresthesia Market Revenues & Volume, By Antivirals, 2021- 2031F |
6.2.6 United States (US) Paresthesia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Paresthesia Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Paresthesia Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.3 United States (US) Paresthesia Market Revenues & Volume, By Direct Tenders, 2021- 2031F |
6.4 United States (US) Paresthesia Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Paresthesia Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United States (US) Paresthesia Market Revenues & Volume, By Topical, 2021- 2031F |
6.4.4 United States (US) Paresthesia Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.5 United States (US) Paresthesia Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Paresthesia Market, By End- Users |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Paresthesia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United States (US) Paresthesia Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 United States (US) Paresthesia Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 United States (US) Paresthesia Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Paresthesia Market Import-Export Trade Statistics |
7.1 United States (US) Paresthesia Market Export to Major Countries |
7.2 United States (US) Paresthesia Market Imports from Major Countries |
8 United States (US) Paresthesia Market Key Performance Indicators |
8.1 Patient satisfaction scores with paresthesia treatment |
8.2 Adoption rate of neuromodulation devices for paresthesia in the United States |
8.3 Number of clinical trials and research studies on paresthesia treatment efficacy |
8.4 Average waiting time for paresthesia treatment in healthcare facilities |
8.5 Rate of complications or adverse events associated with neuromodulation devices for paresthesia |
9 United States (US) Paresthesia Market - Opportunity Assessment |
9.1 United States (US) Paresthesia Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Paresthesia Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Paresthesia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 United States (US) Paresthesia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United States (US) Paresthesia Market Opportunity Assessment, By End- Users, 2021 & 2031F |
10 United States (US) Paresthesia Market - Competitive Landscape |
10.1 United States (US) Paresthesia Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Paresthesia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here